|
This guidance emphasises the potential of NGS methods in mitigating safety risks associated with therapies incorporating genome editing.
|
 |
|
The biotech says that its AKT1 blockers can overcome toxicity challenges associated with PI3K/AKT inhibitors through selective activity.
|
|
|
Zai Lab will supply zoci while Boehringer Ingelheim will manage operations, with both companies retaining rights to their compounds.
|
|
|
Under the partnership, Sirona Dx oversees assay design, development and validation, ensuring quality image production.
|
|
|
CrossBridge Bio develops a dual-payload ADC technology created by Kyoji Tsuchikama at the University of Texas Health Science Center.
|
|
